16-29813694-G-C
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_145239.3(PRRT2):c.640G>C(p.Ala214Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000802 in 1,355,752 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A214G) has been classified as Uncertain significance.
Frequency
Consequence
NM_145239.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_145239.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PRRT2 | NM_145239.3 | MANE Select | c.640G>C | p.Ala214Pro | missense | Exon 2 of 4 | NP_660282.2 | ||
| PRRT2 | NM_001256442.2 | c.640G>C | p.Ala214Pro | missense | Exon 2 of 3 | NP_001243371.1 | |||
| PRRT2 | NM_001438121.1 | c.640G>C | p.Ala214Pro | missense | Exon 2 of 3 | NP_001425050.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PRRT2 | ENST00000358758.12 | TSL:1 MANE Select | c.640G>C | p.Ala214Pro | missense | Exon 2 of 4 | ENSP00000351608.7 | ||
| ENSG00000280893 | ENST00000609618.2 | TSL:5 | n.640G>C | non_coding_transcript_exon | Exon 2 of 6 | ENSP00000476774.2 | |||
| PRRT2 | ENST00000567659.3 | TSL:2 | c.640G>C | p.Ala214Pro | missense | Exon 2 of 3 | ENSP00000456226.1 |
Frequencies
GnomAD3 genomes AF: 0.000916 AC: 137AN: 149504Hom.: 2 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00152 AC: 206AN: 135540 AF XY: 0.00165 show subpopulations
GnomAD4 exome AF: 0.000802 AC: 1087AN: 1355752Hom.: 1 Cov.: 36 AF XY: 0.000836 AC XY: 562AN XY: 672552 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000909 AC: 136AN: 149604Hom.: 2 Cov.: 31 AF XY: 0.000876 AC XY: 64AN XY: 73022 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
PRRT2: BP4, BS1, BS2
This variant is associated with the following publications: (PMID: 23496026, 27123484, 22101681, 26598493, 24594579, 27907910, 31124310)
not specified Benign:1
Episodic kinesigenic dyskinesia Benign:1
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
PRRT2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at